AI assistant
MEDICLIN AG — Board/Management Information 2011
Sep 16, 2011
280_rns_2011-09-16_7bd5704b-ca2a-4379-9e0a-110671bfa55c.html
Board/Management Information
Open in viewerOpens in your device viewer
News Details
Corporate | 16 September 2011 14:56
MediClin AG: Asklepios increases its share in MediClin AG and with 52.73 per cent holds
MediClin AG / Key word(s): Merger/Change of Personnel
16.09.2011 / 14:56
Asklepios increases its share in MediClin AG and with 52.73 per cent holds now the majority of shares
The chairman of the Management Board of MediClin AG will be Chairman of Corporate Management of Asklepios Group
Offenburg, September 16, 2011 – Today MEDICLIN Aktiengesellschaft (MediClin AG) was informed by Asklepios Kliniken GmbH, Hamburg), that Asklepios will increase its share in the subscribed capital of MediClin AG from 34.72 per cent up to 52.73 per cent. In this context MediClin AG was informed that Asklepios Kliniken GmbH has purchased over-the-counter in total 8,556,897 MediClin shares (this corresponds to about 18.01 per cent of the share capital of MediClin AG). The transfer is expected to take place on September 26, 2011. Acquired was a block of shares of Provinzial Rheinland Lebensversicherung AG Die Versicherung der Sparkassen, Düsseldorf, which Asklepios already was entitled to purchase since 2009.
In March this year Asklepios Kliniken GmbH offered a voluntary takeover offer and announced that by increasing its share in MediClin AG it sees a chance to strengthen its position in the German hospital market and to push the business modell integrated medical care of MediClin AG further.
In the context of the above mentioned majority shareholding the Supervisory Board of Asklepios Kliniken GmbH, Hamburg, decided to appoint Dr. Ulrich Wandschneider, Chairman of the Management Board of MediClin AG, as Chairman of Corporate Management of Asklepios Klinik GmbH, effective November 1, 2011. On this date Dr. Wandschneider will take over the chair of Corporate Management of the Asklepios On this date, Dr. Wandschneider will resign as Chairman of the Management Board of MediClin AG but will be still Member of the Management Board of the Company. He will administrate a large part of his present functions at MediClin AG. It is intended that Frank Abele, CFO of MediClin AG, will take the role as Spokesman of the Management Board of MediClin AG.
‘Through the personal arrangement the preconditions are set, to allow a fast and smooth cooperation between the two Company Groups – for the benefit of both Companies’, said Dr. Jan Boetius, Chairman of the Supervisory Board of MediClin AG
Über die MediClin AG (Ticker: MED; WKN: 659 510)
Die MediClin ist ein bundesweit tätiger Klinikbetreiber und ein großer Anbieter in den Bereichen Neuro- und Psychowissenschaften sowie Orthopädie. Mit 34 Klinikbetrieben, sieben Pflegeeinrichtungen und elf Medizinischen Versorgungszentren ist die MediClin in elf Bundesländern präsent und verfügt über eine Gesamtkapazität von rund 8.000 Betten. Bei den Kliniken handelt es sich um Akutkliniken der Grund-, Regel- und Schwerpunktversorgung sowie um Fachkliniken für die medizinische Rehabilitation. Für die MediClin arbeiten rund 8.200 Mitarbeiter.
End of Corporate News
16.09.2011 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
| Language: | English |
| Company: | MediClin AG |
| Okenstraße 27 | |
| 77652 Offenburg | |
| Germany | |
| Phone: | +49 (0)781 488-189 |
| Fax: | +49 (0)781 488-184 |
| E-mail: | [email protected] |
| Internet: | www.mediclin.de |
| ISIN: | DE0006595101 |
| WKN: | 659510 |
| Listed: | Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart |
| End of News | DGAP News-Service |
| - - - |
| 139587 16.09.2011 |